Investment in life sciences has been off the charts since the onset of the pandemic, but that's not a sustainable level of growth for any industry, so it is naturally beginning to taper, according to Mark Goodman, the principal of Mark Goodman & Associates.
Goodman's firm has tracked real estate development trends for 40 years.
"When you also factor in the current economic uncertainty, that has led to the pause button being hit on some projects and a complete stoppage on others," he tells GlobeSt.com.
Want to continue reading?
Become a Free ALM Digital Reader.
Once you are an ALM Digital Member, you’ll receive:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
*May exclude premium content© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
